Literature DB >> 12136374

A Swedish case-control network for studies of drug-induced morbidity--acute pancreatitis.

Kerstin B Blomgren1, Anders Sundström, Gunnar Steineck, Sven Genell, Svante Sjöstedt, Bengt-Erik Wiholm.   

Abstract

OBJECTIVE: To evaluate risk factors - notably drugs - for developing acute pancreatitis.
METHODS: A population-based, case-control study, encompassing 1.4 million inhabitants aged 20-85 years from four regions in Sweden between 1 January 1995 and 31 May 1998. A total of 462 cases were hospitalised in surgical departments with their first episode of acute pancreatitis without previously known biliary stone disease. From a population register, 1781 controls were randomly selected. Information was obtained from medical records and through telephone interviews.
RESULTS: Fifty-seven percent of the cases were males. An expert group found evidence for biliary stones in 50% of the cases, alcohol intake in 23%, but in 29% neither of these factors were present. In all, "other" factors, e.g. drugs, could have contributed to the development of acute pancreatitis in 52% of the cases. In a multivariate analysis, the adjusted odds ratios (ORs) for H(2) antagonists were 2.4 (95% CI 1.2-4.8) for proton pump inhibitors (PPIs), 2.1 (1.2-3.4) for non-steroidal anti-inflammatory drugs (NSAIDs), 2.3 (1.3-4.0) for those derived from acetic acid and 1.9 (1.1-3.2) for antibacterials for systemic use. Significant ORs were found for a history of gastrointestinal tract disorders [1.5 (1.1-1.9)] and inflammatory bowel disease (IBD) [3.4 (1.5-7.9)]. Smoking was significantly associated with acute pancreatitis [1.7 (1.2-2.1)] and, for those smoking more than 20 cigarettes per day, the OR was 4.0 (2.2-7.5). Alcohol in moderate amounts did not increase the risk, but for those drinking more than 420 g alcohol per week the OR was 4.1 (2.2-7.5).
CONCLUSION: In addition to cholelithiasis, smoking and heavy alcohol use, drugs may be an important risk factor for acute pancreatitis.

Entities:  

Mesh:

Year:  2002        PMID: 12136374     DOI: 10.1007/s00228-002-0471-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Interviewer variability - quality aspects in a case-control study.

Authors:  Kerstin J Blomgren; Anders Sundström; Gunnar Steineck; Bengt-Erik Wiholm
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

2.  Increased Risk of Acute Pancreatitis with Codeine Use in Patients with a History of Cholecystectomy.

Authors:  Juhyeun Kim; Andrew John Tabner; Graham David Johnson; Babette A Brumback; Abraham Hartzema
Journal:  Dig Dis Sci       Date:  2019-08-29       Impact factor: 3.199

3.  Epidemiologic and Mechanistic Associations Between Smoking and Pancreatitis.

Authors:  Julia B Greer; Edwin Thrower; Dhiraj Yadav
Journal:  Curr Treat Options Gastroenterol       Date:  2015-09

4.  Idiopathic acute pancreatitis: a single-center investigation of clinical and biochemical features.

Authors:  Giovanna Del Vecchio Blanco; Cristina Gesuale; Diana Giannarelli; Marzia Varanese; Diego Fiume; Giovanni Monteleone; Omero Alessandro Paoluzi
Journal:  Intern Emerg Med       Date:  2020-04-03       Impact factor: 3.397

5.  Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  Eur J Clin Pharmacol       Date:  2017-08-30       Impact factor: 2.953

6.  Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan.

Authors:  Shih-Chang Hung; Shih-Rong Hung; Cheng-Li Lin; Shih-Wei Lai; Hung-Chang Hung
Journal:  Am J Gastroenterol       Date:  2015-09-01       Impact factor: 10.864

Review 7.  Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis.

Authors:  Hyacinth M Irving; Andriy V Samokhvalov; Jürgen Rehm
Journal:  JOP       Date:  2009-07-06

8.  Alcohol use and cigarette smoking as risk factors for post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Anthony T Debenedet; Trivellore E Raghunathan; Jeffrey J Wing; Erik-Jan Wamsteker; Matthew J DiMagno
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-03       Impact factor: 11.382

9.  JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis.

Authors:  Miho Sekimoto; Tadahiro Takada; Yoshifumi Kawarada; Koichi Hirata; Toshihiko Mayumi; Masahiro Yoshida; Masahiko Hirota; Yasutoshi Kimura; Kazunori Takeda; Shuji Isaji; Masaru Koizumi; Makoto Otsuki; Seiki Matsuno
Journal:  J Hepatobiliary Pancreat Surg       Date:  2006

Review 10.  Corticosteroid treatment for acute/acute-on-chronic experimental and naturally occurring pancreatitis in several species: a scoping review to inform possible use in dogs.

Authors:  Kari-Anne Bjørnkjær-Nielsen; Charlotte Reinhard Bjørnvad
Journal:  Acta Vet Scand       Date:  2021-07-13       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.